BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

Overview of attention for article published in New England Journal of Medicine, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 36 news outlets
blogs: 3 blogs
twitter: 154 X users
facebook: 1 Facebook page

reddit: 1 Redditor
f1000: 1 research highlight platform
video: 1 YouTube creator

Readers on

mendeley: 82 Mendeley

So far, Altmetric has seen 179 X posts from 154 X users, with an upper bound of 1,478,989 followers.

RT @PDBrownOnc: Craniopharyngioma week 5/5 BRAF & MEK inhib newly diagnosed Papillary Craniopharyngiomas • 94% response rate, vast majority…

Craniopharyngioma week 5/5 BRAF & MEK inhib newly diagnosed Papillary Craniopharyngiomas • 94% response rate, vast majority durable • Future less aggressive surgery • ?? adjuvant vs salvage RT https://t.co/oEu2zdi0Sg

RT @EricTopol: The power of genomics to drive effective treatment for a rare brain tumor "Our discovery that more than 90% of papillary cra…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 175 additional X posts.